Oxelumab
Monoclonal antibody From Wikipedia, the free encyclopedia
Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]
 | This article relies largely or entirely on a single source. (January 2024) |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | OX-40 ligand |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C6424H9920N1704O2014S42 |
| Molar mass | 144594.46 g·mol−1 |
| (what is this?) (verify) | |
Oxelumab was developed by Genentech and co-developed by Roche.
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.